Doz-Cevap İlişkisi: Genel Bakış

The magnitude of a pharmacologic response is directly proportional to the fraction of activated receptors, which depends on drug concentration at the receptor site. As administered dose increases, drug concentration rises, resulting in stronger biological response. This relationship continues until receptors become fully saturated, at which point maximum effect is achieved regardless of further dose increases.

Agonists bind to and activate receptors, forming drug-receptor complexes that initiate various biochemical processes at the cellular level. These complexes catalyze signal transduction pathways, ultimately leading to a measurable pharmacologic response. The strength of this response depends on how many receptors are activated and the sensitivity of those receptors to the drug.

The EC50 value represents the drug concentration required to reach half of the maximum effect, serving as a key measure of drug potency. A lower EC50 indicates greater potency, meaning the drug produces a significant response at lower concentrations. This value is determined by plotting the dose-response relationship and identifying where the response reaches 50% of maximum.

The Emax value determines a drug's efficacy, representing the maximum therapeutic effect the drug can produce when receptors are fully saturated. Unlike EC50, which measures potency and indicates drug concentration needed for half-maximal response, Emax reflects the ceiling of the drug's biological effect. Both values are essential for characterizing complete dose-response relationships.

The graded dose-response curve is hyperbolic when plotted linearly, but becomes sigmoidal when plotted semi-logarithmically. This transformation occurs because the logarithmic scale compresses the lower concentration range while expanding the higher range, converting the hyperbolic curve into an S-shaped sigmoid. The sigmoidal representation effectively illustrates drug potency and efficacy across the full concentration range.

Once receptors attain complete saturation, the maximum effect of the drug is observed, and further increases in dose produce no additional response. At this point, all available receptors are activated and forming drug-receptor complexes. The response plateau represents the drug's maximum efficacy, beyond which no additional biological effect can be achieved regardless of dose escalation.

Receptor sensitivity directly influences the dose-response relationship by determining how readily receptors bind to and activate in response to a drug. The degree of pharmacologic response depends not only on drug concentration but also on receptor sensitivity at the target site. Variations in receptor sensitivity can shift the dose-response curve, affecting both potency measurements and the concentration needed to achieve therapeutic effects.